{
  "docId": "019de075-1718-756f-8ae4-37f1cf0d16ed",
  "docSlug": "2a95ead0d9ef429fb8fb8c2cc4a7d704",
  "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 52 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 52,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "other",
  "function": "present_framework",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The diagram illustrates a hub-and-spoke model where the central hub is 'Diverse portfolio for combinations' and the spokes are the various therapeutic areas.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de075-1718-756f-8ae4-37f1cf0d16ed/9",
  "deckHref": "/decks/019de075-1718-756f-8ae4-37f1cf0d16ed",
  "deckJsonHref": "/decks/019de075-1718-756f-8ae4-37f1cf0d16ed.json",
  "deckAnchorHref": "/decks/019de075-1718-756f-8ae4-37f1cf0d16ed#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.36,
        "x": 0.32,
        "y": 0.28
      },
      "kind": "diagram",
      "text": "Hub-and-spoke diagram showing therapeutic areas surrounding a central portfolio focus",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07515fce-668d-4c31-b841-a7264aeff5c0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.94,
        "x": 0.03,
        "y": 0.91
      },
      "kind": "disclaimer",
      "text": "GPC3 CAR-T = glypican 3 protein... [abbreviations list]",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ce0ea46-d42d-4eca-9ee9-c2a66966d7c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.06,
        "y": 0.033
      },
      "kind": "list",
      "text": "Cell therapy: armoured GPC3 CAR-T, NT-125 (TCR-T)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "391d66f4-ea2f-461b-b2f2-98bd677581f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.68,
        "y": 0.28
      },
      "kind": "list",
      "text": "ADCs + RCs: Dato-DXd, AZD8205, AZD9592, AZD0901",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d7f57a4-8844-4f19-9873-a14428f2c091",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.68,
        "y": 0.45
      },
      "kind": "list",
      "text": "DNA Damage Response: ceralasertib, AZD9574, saruparib, AZD1390",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8955efab-00ae-458a-a57e-7fef2456acf5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.06,
        "y": 0.53
      },
      "kind": "list",
      "text": "Immune engagers: AZD0486 (CD19xCD3)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7771822-847f-47d2-b902-0a35480232f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.68,
        "y": 0.62
      },
      "kind": "list",
      "text": "Tumour Drivers and Resistance: capivasertib, camizestrant, AZD4573, AZD0466",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd22ffe5-57be-4492-bd2f-dfaeaaec1e8b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.06,
        "y": 0.072
      },
      "kind": "list",
      "text": "Immuno-oncology: oleclumab, monalizumab, volrustomig, rilvegostomig, IPH5201, AZD0171, AZD7789",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e1bb6285-5c77-4a82-8316-b71fecf0cb36",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.8,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Diverse portfolio of novel modalities and medicines, supporting potential combinations",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "409a63c7-b694-4a64-ac8d-a8f66e5974a3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.4,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "AstraZeneca in oncology",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8a9dffe-e9b6-4e29-83eb-f90ba9d6c310",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "NxN matrix",
      "slug": "matrix-nxn",
      "agent": null,
      "layer": "slide",
      "matchId": "0688b43a-e4d6-4430-be09-c30a6f6b507b",
      "evidence": "The slide presents a hub-and-spoke diagram with various therapeutic areas.",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "hub-spoke",
      "slug": null,
      "matchId": "df439fe6-879d-4385-a019-837df940ba1a",
      "evidence": "Central hub with surrounding spokes representing therapeutic areas",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 8,
      "beatId": "825356c1-11c2-4d2a-9dc4-e3ccfd780129",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The deck highlights the company's diverse portfolio and pipeline, emphasizing the potential for combinations",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 8,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5bb0992b-1a81-4416-bc2d-f98f5d61437b",
      "evidence": "The deck highlights the company's diverse portfolio and pipeline, implying that innovation is crucial",
      "position": 0,
      "objective": "What if AstraZeneca doesn't innovate in oncology?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}